Andrew John Phillips's Net Worth
$0
Who is Andrew John Phillips?
Andrew John Phillips does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MoonLake Immunotherapeutics, and Enliven Therapeutics, Inc..
SEC CIK
Andrew John Phillips's CIK is 0001921956
Past Insider Trading and Trends
2023 was Andrew John Phillips's most active year for acquiring shares with 2 total transactions. Andrew John Phillips's most active month to acquire stocks was the month of January. 2022 saw Andrew John Phillips paying a total of $0.00 for 45,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MoonLake Immunotherapeutics (MLTX) Snapshot price: $58.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||